29 research outputs found
Rituximab for Children with Immune Thrombocytopenia: A Systematic Review
BACKGROUND: Rituximab has been widely used off-label as a second line treatment for children with immune thrombocytopenia (ITP). However, its role in the management of pediatric ITP requires clarification. To understand and interpret the available evidence, we conducted a systematic review to assess the efficacy and safety of rituximab for children with ITP. METHODOLOGY/PRINCIPAL FINDINGS: We searched MEDLINE, EMBASE, Cochrane Library, CBM, CNKI, abstract databases of American Society of Hematology, American Society of Clinical Oncology and Pediatric Academic Society. Clinical studies published in full text or abstract only in any language that met predefined inclusion criteria were eligible. Efficacy analysis was restricted to studies enrolling 5 or more patients. Safety was evaluated from all studies that reported data of toxicity. 14 studies (323 patients) were included for efficacy assessment in children with primary ITP. The pooled complete response (platelet count ≥ 100 × 10(9)/L) and response (platelet count ≥ 30 × 10(9)/L) rate after rituximab treatment were 39% (95% CI, 30% to 49%) and 68% (95%CI, 58% to 77%), respectively, with median response duration of 12.8 month. 4 studies (29 patients) were included for efficacy assessment in children with secondary ITP. 11 (64.7%) of 17 patients associated with Evans syndrome achieved response. All 6 patients with systemic lupus erythematosus associated ITP and all 6 patients with autoimmune lymphoproliferative syndrome associated ITP achieved response. 91 patients experienced 108 adverse events associated with rituximab, among that, 91 (84.3%) were mild to moderate, and no death was reported. CONCLUSIONS/SIGNIFICANCE: Randomized controlled studies on effect of rituximab for children with ITP are urgently needed, although a series of uncontrolled studies found that rituximab resulted in a good platelet count response both in children with primary and children secondary ITP. Most adverse events associated with rituximab were mild to moderate, and no death was reported
Effects of magnetic field gradients on the aggregation dynamics of colloidal magnetic nanoparticles
Measuring empathy in pediatrics: validation of the Visual CARE measure
Background: Empathy is a key element of “Patient and Family Centered Care”, a clinical approach recommended
by the American Academy of Pediatrics. However, there is a lack of validated tools to evaluate paediatrician
empathy. This study aimed to validate the Visual CARE Measure, a patient rated questionnaire measuring physician
empathy, in the setting of a Pediatric Emergency Department (ED).
Methods: The empathy of physicians working in the Pediatric ED of the University Hospital of Udine, Italy, was
assessed using an Italian translation of the Visual Care Measure. This test has three versions suited to different age
groups: the 5Q questionnaire was administered to children aged 7–11, the 10Q version to those older than 11, and
the 10Q–Parent questionnaire to parents of children younger than 7.
The internal reliability, homogeneity and construct validity of the 5Q and 10Q/10Q–Parent versions of the Visual
Care Measure, were separately assessed. The influence of family background on the rating of physician empathy
and satisfaction with the clinical encounter was also evaluated.
Results: Seven physicians and 416 children and their parents were included in the study. Internal consistency
measured by Cronbach’s alpha was 0.95 for the 10Q/10Q–Parent versions and 0.88 for the 5Q version. The
item-total correlation was > 0.75 for each item. An exploratory factor analysis showed that all the items load
onto the first factor.
Physicians’ empathy scores correlated with patients’ satisfaction for both the 10Q and 10Q–Parent questionnaires
(Spearman’s rho = 0.7189; p < 0.001) and for the 5Q questionnaire (Spearman’s rho = 0.5968; p < 0,001). Trust in the
consulting physician was lower among immigrant parents (OR 0.43. 95% CI 0.20–0.93).
Conclusions: The Visual Care Measure is a reliable second-person test of physician empathy in the setting of a
Pediatric Emergency Room. More studies are needed to evaluate the reliability of this instrument in other pediatric
settings distinct from the Emergency Room and to further evaluate its utility in measuring the impact of
communication and empathy training programmes for healthcare professionals working in pediatrics
Molecular structure and semiexternal molecular motions in 2,4,5-trichlorobenzenesulfonyl chloride, C6H2Cl4O2S
Molecular structure and semiexternal molecular motions in 2,4,5-trichlorobenzenesulfonyl chloride, C6H2Cl4O2S
The molecular structure of 2,4,5-trichlorobenzenesulfonyl chloride has been determined by X-ray diffraction methods. The compound is orthorhombic,Aba2, witha=16.253(12),b=17.016(9),c=7.146(5) A,V=1976(5) A3,Z=8,D=1.88 kg·mm−3, (MoKα)=0.7107 A,μ=136.8 cm−1,F(000)=1104. Data were obtained at room temperature; the finalR is 0.029 for 854 independent reflections. The substituted benzene ring is planar within experimental accuracy, the dihedral angle with the C(1)-S(1)-Cl(1) plane being 66.0(5)°. The compound has normal bond lengths and angles; some short intramolecular distances account for the maintenance of the rigid benzene frame. No significatively short intermolecular distances have been found. Confirmation of the oscillatory character of the semiexternal molecular motions operating above 180 K is accounted for.Facultad de Ciencias Exacta